MarketInOut Stock Screener Log In | Sign Up

CSL Ltd

Healthcare • Biotechnology • Quote as of 10/29/2026 16:11
CSL Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization93,645 mln
Float480 mln
Earnings Date02/09/2027

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.37
Reliable

1-Year Forecast

186.33
Limited downside

Relative Strength

85 / 100
Strongly outperforming

Debt / Equity

0.74
Moderate leverage

Pre-Tax Margin

-25%
Deeply loss-making

Business Description

CSL Limited is a global healthcare company founded in 1916 and based in Melbourne, Australia, that develops and delivers medicines and vaccines to patients in dozens of countries. Its core work covers treatments for blood and immune disorders, heart and metabolic conditions, kidney disease, and iron deficiency, as well as flu vaccines supplied to governments worldwide. The company collects and processes plasma, a component of human blood, to produce many of its most important therapies.

Key Fundamentals

EPS-7.99
ROE-13.81
RPS46.85
ROIC9.19
ROA-6.58
Interest Cover9.40
EBITDA, mln-3,612
EV / EBITDA-28.57
EV / EBIT-20.06
Revenue, mln23,196
EV / Revenue4.45

Quote Details

Last 197.50
Change 0.4 (0.2%)
Open 197.00
Volume 896,782
Turnover 177,114,448
Average Volume 988,682

Financial Ratios

Pre-Tax Profit Margin-25
Leverage Ratio2.27
Current Ratio2.21
Price / Book3.75
Price / Tangible Book11.32
Price / Cash Flow19.22
Price / Free Cash Flow21.75
Debt / Equity0.74
Price / Sales3.83
PEG Ratio1.82

Financial Strength

Altman Z-Score3.01
Piotroski F-Score 4 / 9
Beneish M-Score-3.37
Price to Intrinsic Value1.70
Price to Graham Number3.22
1-Year Target Price186.33
Shiller PE Ratio29.09

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.69% 64 / 100   
1 Month 7.21% 90 / 100   
2 Months 71.92% 99 / 100   
6 Months 60.84% 97 / 100   
1 Year 13.57% 80 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog